Downregulation of CD45 Signaling in COVID-19 Patients Is Reversed by C24D, a Novel CD45 Targeting Peptide

Danny Alon, Yossi Paitan, Eyal Robinson, Nirit Ganor, Julia Lipovetsky, Rinat Yerushalmi, Cyrille J. Cohen, Annat Raiter*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

5 Scopus citations

Fingerprint

Dive into the research topics of 'Downregulation of CD45 Signaling in COVID-19 Patients Is Reversed by C24D, a Novel CD45 Targeting Peptide'. Together they form a unique fingerprint.

Medicine & Life Sciences